| Product NDC: | 0078-0400 |
| Proprietary Name: | Lopressor |
| Non Proprietary Name: | metoprolol tartrate |
| Active Ingredient(s): | 5 mg/5mL & nbsp; metoprolol tartrate |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0078-0400 |
| Labeler Name: | Novartis Pharmaceuticals Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA018704 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19780115 |
| Package NDC: | 0078-0400-01 |
| Package Description: | 10 AMPULE in 1 CARTON (0078-0400-01) > 5 mL in 1 AMPULE (0078-0400-61) |
| NDC Code | 0078-0400-01 |
| Proprietary Name | Lopressor |
| Package Description | 10 AMPULE in 1 CARTON (0078-0400-01) > 5 mL in 1 AMPULE (0078-0400-61) |
| Product NDC | 0078-0400 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | metoprolol tartrate |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19780115 |
| Marketing Category Name | NDA |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Substance Name | METOPROLOL TARTRATE |
| Strength Number | 5 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |